Gelteq Limited (NASDAQ:GELS) Short Interest Up 2,478.9% in January

Gelteq Limited (NASDAQ:GELS) was the target of a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 1,003,425 shares, a growth of 2,478.9% from the December 31st total of 38,909 shares. Based on an average daily trading volume, of 5,802,384 shares, the short-interest ratio is presently 0.2 days. Approximately 10.6% of the company’s shares are short sold. Approximately 10.6% of the company’s shares are short sold. Based on an average daily trading volume, of 5,802,384 shares, the short-interest ratio is presently 0.2 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Gelteq in a research note on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

Gelteq Stock Performance

Shares of GELS stock opened at $1.03 on Thursday. Gelteq has a twelve month low of $0.67 and a twelve month high of $4.11. The stock has a fifty day simple moving average of $0.97 and a two-hundred day simple moving average of $1.24.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Gelteq stock. Susquehanna International Group LLP bought a new stake in shares of Gelteq Limited (NASDAQ:GELS) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned 0.44% of Gelteq as of its most recent filing with the Securities and Exchange Commission.

About Gelteq

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.